News & Press
Blog Home All Blogs
Search all posts for:   

 

View all (511) posts »
 

Surgical Specialties Corporation Announces Medicare Approval of Transitional Pass-Through Reimbursement for BioSentry™ Track Sealant System

Posted By ASC, Tuesday, June 30, 2015
The U.S. Centers for Medicare and Medicaid Services have approved transitional pass-through payment on a new biomedical sealant system, thereby removing a barrier to patient’s receiving treatment with this system. The approval is for the BioSentryTM Track Sealant System, which has been approved by the US FDA for used in percutaneous transthoracic lung biopsies. The BioSentryTM System delivers a plug of hydrogel sealant to the lung along the biopsy needle’s track. The hydrogel expands and prevents air from leaking out of the lung into the chest cavity, a dangerous condition called a pneumothorax. Pneumothorax is the most common, costly and care-intensive complication from this type of biopsy and occurs in 15-42% of patients. However, in a randomized trial with 339 patients, the use of the BioSentryTM Track Sealant System reduced the risk of pneumothorax by more than 50%. With this payment approval, doctors can more readily offer this simple, effective sealing procedure and improve patient outcomes.

Tags:  Industry News 

Share |
Permalink | Comments (0)
 
Membership Software Powered by YourMembership  ::  Legal